investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides 

Dennis Klinman

8 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Imtiaz Mawji

Bioensemble, LTD

Mississuaga, Canada

Related projects

Erika L Pearce

Tumor-Imposed Glucose Restrictions on T Cells Dampen Immunity

All cancers but non-melanoma skin cancer

Sun Hur

Structural and functional analyses of the RIG-I filament in innate immunity

All cancers but non-melanoma skin cancer

Larry Keefer

Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies

All cancers but non-melanoma skin cancer

Pathology

Sriram Subramaniam

Technology Development for 3D Electron Microscopy

All cancers but non-melanoma skin cancer

Joel Schneider

Design and Utility of Novel Proteinaceous Biomaterials 

All cancers but non-melanoma skin cancer

Pathology

Hanlee Ji

Oligonucleotide-Selective Sequencing for integrated and rapid cancer genome analy

All cancers but non-melanoma skin cancer

Pathology

Investigator from University of Würzburg

N-Myc and Aurora A: From Protein Stability to Chromosome Topology

All cancers but non-melanoma skin cancer

Michael Bustin

Chromosomal Proteins and Chromosomal Functions

All cancers but non-melanoma skin cancer

Charles D Allis

Oncohistones: Role of Histone H3 Mutations in the Oncogenesis of Pediatric Cancers

All cancers but non-melanoma skin cancer

Pediatric oncology or childhood cancer